| Old Articles: <Older 4101-4110 Newer> |
|---|
 |
The Motley Fool
September 6, 2007
Brian Lawler |
Foolish Fantasy Football: InterMune on Special Teams This stock analyst chooses developmental stage drugmaker InterMune as his speculative bet.   |
The Motley Fool
September 6, 2007
Brian Lawler |
Foolish Fantasy Football: GlaxoSmithKline on Defense In real life, defense wins championships. This stock analyst includes GlaxoSmithKline on his fantasy football investment team, to shield from a punishing sack by the market. |
Reason
Aug/Sep 2007
Kerry Howley |
Dying for Lifesaving Drugs Will desperate patients destroy the pharmaceutical system that produces tomorrow's treatments? |
The Motley Fool
September 5, 2007
Ryan Fuhrmann |
Foolish Forecast: A Test From BioReference Labs In advance of lab-testing firm BioReference Labs Q3 earnings report, analysts are predicting another quarter of double-digit earnings for the small but fast-growing regional company. |
The Motley Fool
September 5, 2007
Brian Lawler |
Not Your Typical Product Recall Shire and Noven will fix an annoying foible of their ADHD patch, Daytrana, making the back adhesive easier to unpeel. |
The Motley Fool
September 5, 2007
Billy Fisher |
Lilly's Pipeline Continues to Produce Another schizophrenia drug from the company shows promise in a clinical trial, prompting the company to plan additional trials. This is the latest good news in what has been a good year for Lilly. |
The Motley Fool
September 4, 2007
Rich Duprey |
Pain in Mylan's Future Competition for painkiller patch may prove to be a major pain for the generics maker Mylan. The stock has dropped precipitously from its highs, and while it's recovered some, its immediate outlook is cloudy. |
Managed Care
August 2007 |
Consumer-Directed Health Plans: Built to Last or Designed to Fail? A point-counterpoint debate about the effect of CDHPs on overall health and health care costs. |
Managed Care
August 2007 |
E-mailing Doctors Desirable for Those with Comorbidities Patients who have multiple comorbidities and who take multiple medications may benefit most from a secure e-mail messaging system, according to a study. |
Managed Care
August 2007 |
Headlines On Deadline ... A survey finds that many employees struggle with basic health benefit terms... Old matches new when it comes to oral diabetes drugs... |
| <Older 4101-4110 Newer> Return to current articles. |
